| Literature DB >> 28468326 |
Ousseynou Sarr1, Rachel Joyce Strohm2, Tara Lynn MacDonald3, Nicholas Gaudio4, John Kenneth Reed5, Jules Foute-Nelong6, David James Dyck7, David Michael Mutch8.
Abstract
Adipose tissue plays a key role in the development of type-2 diabetes via the secretion of adipokines. The current study investigated if secretion media derived from intact visceral (VAT) and subcutaneous (SAT) adipose tissues from extremely obese men and women differently suppressed insulin signaling in human skeletal myotubes derived from a healthy, non-diabetic male and female donor, respectively. Adipose tissue samples were collected from men and women during laparoscopic bariatric surgery. In general, secretion media collected from both SAT and VAT depots caused impaired insulin signaling in myotubes, independent of sex. In females, this was true regardless of the protein kinase B (Akt) phosphorylation site (Akt Thr308 and Akt Ser473) assessed (p < 0.01). In males, both SAT and VAT secretion media reduced Akt Thr308 activation in insulin-stimulated myotubes compared to controls (p < 0.001); however, only the VAT secretion media impaired Akt Ser473 phosphorylation. Independent of sex, 13 out of 18 detected cytokines, chemokines, and growth factors were more abundant in VAT versus SAT secretion media (p < 0.01). Both SAT and VAT secretion media from obese men and women acutely suppress insulin signaling in myotubes, despite different secretion profiles. We propose that this crosstalk model will help to extend our understanding of the interplay between adipose and muscle, as well as the pathogenesis of type-2 diabetes.Entities:
Keywords: adipokines; crosstalk; muscle insulin resistance; white adipose tissue
Mesh:
Substances:
Year: 2017 PMID: 28468326 PMCID: PMC5454872 DOI: 10.3390/ijms18050959
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Human skeletal myotubes were incubated for 24 h with either control M199 or secretion media from visceral adipose tissue (VAT) or subcutaneous adipose tissue (SAT) of obese men and women. Myotubes were then stimulated acutely with insulin (100 µU/well, 10 min). Total cell lysates (20 µg/lane) were resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted for total protein kinase B (t-Akt), Akt Ser473, Akt Thr308, and α-tubulin. Representative blots for muscle cells incubated with SAT and VAT media from one male donor (a) and one female donor (b) are shown. All phosphorylated Akt data were normalized to t-Akt and are expressed relative to the basal control (CONT) M199 value. Data are mean values ± standard error of the mean (SEM) of 10 different men (c,d) and 17 women (e,f) donors for SAT and VAT samples. **, ***, and “ns” indicate p < 0.01, p < 0.001, and not significant, respectively, for comparisons between insulin-stimulated conditions.
Proteins detected in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) secretion media from men and women.
| Secreted Factor a,b,c | Average in Male SAT | Average in Female SAT | Average in Male VAT | Average in Female VAT | SAT vs. VAT | Male vs. Female | Depot |
|---|---|---|---|---|---|---|---|
| IL-4 | 29.8 ± 7.2 | 40.6 ± 12.4 | 106.7 ± 13.3 † | 110.4 ± 23.3 ** | < 0.001 | 0.689 | 0.846 |
| IL-6 | 388.5 ± 72.1 | 699.6 ± 329.5 | 2183.6 ± 497.8 | 4861.1 ± 1590.1 ** | 0.004 | 0.141 | 0.242 |
| IL-21 | 287.9 ± 15.6 | 285.3 ± 19.3 | 231.9 ± 13.1 | 213.8 ± 14.0 ** | < 0.001 | 0.530 | 0.639 |
| IL-1α | 17.9 ± 0.9 | 18.4 ± 1.3 | 16.4 ± 0.7 | 15.6 ± 1.4 | 0.093 | 0.872 | 0.614 |
| IL-1RA | 65.7 ± 11.3 | 76.4 ± 18.9 | 79.2 ± 19.1 | 99.1 ± 19.9 | 0.349 | 0.427 | 0.813 |
| GRO-α | 50.2 ± 2.2 | 61.3 ± 9.0 | 125.3 ± 28.7 | 178.7 ± 54.6 * | 0.008 | 0.358 | 0.546 |
| IL-8 | 218.5 ± 61.3 | 586.9 ± 222.9 | 1427.5 ± 247.7 | 1866.5 ± 693.5 | 0.007 | 0.365 | 0.937 |
| MCP-1 | 176.2 ± 55.2 | 234.3 ± 109.9 | 844.6 ± 150.3 | 949.8 ± 295.9 * | < 0.001 | 0.682 | 0.906 |
| MIP-1α | 10.6 ± 9.0 | 18.6 ± 39.3 | 29.9 ± 14.8 | 40.2 ± 48.4 | 0.033 | 0.332 | 0.901 |
| MIP-1β | 202.4 ± 11.8 | 214.1 ± 27.8 | 304.1 ± 16.9 | 297.0 ± 53.6 | 0.014 | 0.949 | 0.798 |
| RANTES | 1.9 ± 0.5 | 2.0 ± 0.6 | 4.6 ± 0.4 † | 4.7 ± 1.0 * | < 0.001 | 0.900 | 0.933 |
| SDF-1α | 314.2 ± 65.3 | 260.6 ± 79.6 | 622.2 ± 38.2 | 578.5 ± 114.6 * | 0.001 | 0.593 | 0.956 |
| FGF-2 | 87.3 ± 4.4 | 82.6 ± 6.0 | 70.4 ± 3.2 | 63.8 ± 4.6 * | < 0.001 | 0.262 | 0.852 |
| HGF | 694.3 ± 173.5 | 484.8 ± 101.3 | 950.7 ± 136.2 | 761.4 ± 140.8 | 0.058 | 0.1538 | 0.942 |
| LIF | 32.0 ± 7.0 | 55.4 ± 16.7 | 200.5 ± 32.1 ‡ | 213.6 ± 48.9 ** | <0.001 | 0.589 | 0.879 |
| P IGF-1 | 3.5 ± 0.7 | 2.5 ± 0.8 | 9.3 ± 1.6 † | 8.4 ± 1.8 ** | <0.001 | 0.516 | 0.974 |
| VEGF-A | 117.3 ± 23.6 | 89.4 ± 14.5 | 253.6 ± 53.4 † | 169.9 ± 30.2 | 0.001 | 0.089 | 0.391 |
| Adiponectin | 3679.7 ± 648.2 | 3757.7 ± 565.4 | 3513.4 ± 426.5 | 3939.8 ± 610.0 | 0.989 | 0.670 | 0.769 |
a Secreted factors were expressed in pg/mL per mg/mL of protein in VAT or SAT; Interleukin (IL)-4; IL-6; IL-21; IL-1α; IL-8; Interleukin-1 receptor antagonist (IL-1RA); Growth related oncogene alpha (GRO-α); Monocyte chemoattractant protein-1 (MCP-1); Macrophage inflammatory protein (MIP)-1α; MIP-1β; Regulated on Activation, normal T cell expressed and secreted (RANTES); stromal cell-derived factor -1α (SDF-1α); fibroblast growth factor-2 (FGF-2); Hepatocyte growth factor (HGF); Leukemia inhibitory factor (LIF); Placental growth factor-1 (P IGF-1); Vascular endothelial growth factor-A (VEGF-A); b Undetected adipokines: Brain-derived neurotrophic factor (BDNF); Eotaxin/C-C motif chemokine 11 (CCL11); Epidermal growth factor (EGF); Granulocyte-macrophage colony-stimulating factor (GM-CSF); Nerve growth factor)-β (NGF-β); Interferon (IFN)-α; IFN-γ; IL-1β; IL-2; IL-5; IL-7; IL-9; IL-10; IL-12 p70; IL-13; IL-15; IL-17A; IL-18; IL-22; IL-23; IL-27; IL-31; IP-10/chemokine (C-X-C motif) ligand 1 (CXCL10); Tumor necrosis (TNF)-α; TNF-β/Lymphotoxin-α (LTA); Platelet-derived growth factor-BB (PDGF-BB); Stem cell factor (SCF); VEGF-D; c Secreted factors were analyzed using a two-way ANOVA, with adipose tissue depot and sex as main effects. The interaction between depot and sex was also analyzed. p < 0.05 was considered significant. † and ‡ indicate p < 0.05 and p < 0.01, respectively, for comparisons between SAT and VAT in males after a Bonferroni post hoc test; * and ** indicate p < 0.05 and p < 0.01, respectively, for comparisons between SAT and VAT in females after a Bonferroni post hoc test.